Drugs Made In America Acquisition Corp. Ordinary Shares DMAA NASDAQ

NASDAQ Global Select • Financial Services • Shell Companies • US • USD

Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) 是一家上市公司属于金融服务板块，经营于壳公司行业. 公司总部位于 Fort Lauderdale, FL, 美国. 现任CEO为 Roger Bendelac.

DMAA 拥有 IPO日期为 2025-01-27, 2 名全职员工, 在 NASDAQ Global Select, 市值为 $353.27M.

关于 Drugs Made In America Acquisition Corp. Ordinary Shares

Drugs Made In America Acquisition Corp. operates as a blank check company. The Company aims to acquire one and more businesses and assets, via a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization.

📍 1 East Broward Blvd Suite 700, Fort Lauderdale, FL 33301 📞 (954) 870-3099

公司详情

所属板块金融服务

细分行业壳公司

国家美国

交易所NASDAQ Global Select

货币USD

IPO日期2025-01-27

首席执行官Roger Bendelac

员工数2

交易信息

当前价格$10.54

市值$353.27M

52周区间10.02-10.52

Beta0.00

ETF否

ADR否

其他人也在看

TACOU

Berto Acquisition Corp. Unit

$10.37

+0.29%

ALF

Centurion Acquisition Corp.

$10.81

+0.09%

TACO

Berto Acquisition Corp.

$10.25

0.00%

TACH

Titan Acquisition Corp.

$10.35

+0.29%

OYSE

Oyster Enterprises II Acquisition Corp

$10.21

+0.05%

MLAC

Mountain Lake Acquisition Corp.

$10.57

+0.09%

SIMA

SIM Acquisition Corp. I

$10.67

-0.56%

RTAC

Renatus Tactical Acquisition Corp I Class A Ordinary Shares

$10.30

+0.10%

Drugs Made In America Acquisition Corp. Ordinary Shares DMAA NASDAQ

关于 Drugs Made In America Acquisition Corp. Ordinary Shares

其他人也在看

获取低估股票提醒